Covered recipient · General Payments record
WILLIAM W KING
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,895.73
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $682.39 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $361.53 | 21 |
| PENTAX OF AMERICA, INC. | $92.99 | 3 |
| Ferring Pharmaceuticals Inc. | $92.24 | 1 |
| Janssen Biotech, Inc. | $38.57 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $36.01 | 2 |
| PFIZER INC. | $32.69 | 2 |
| Medtronic, Inc. | $14.76 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.29 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078804 | CMS |
| ABBVIE INC. | $33.26 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078806 | CMS |
| ABBVIE INC. | $19.14 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078808 | CMS |
| ABBVIE INC. | $27.86 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078810 | CMS |
| ABBVIE INC. | $8.45 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078812 | CMS |
| ABBVIE INC. | $20.12 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078814 | CMS |
| ABBVIE INC. | $30.95 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078816 | CMS |
| ABBVIE INC. | $19.51 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078818 | CMS |
| ABBVIE INC. | $8.07 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078820 | CMS |
| ABBVIE INC. | $12.79 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078822 | CMS |
| ABBVIE INC. | $15.93 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078824 | CMS |
| ABBVIE INC. | $19.82 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078826 | CMS |
| ABBVIE INC. | $13.52 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078828 | CMS |
| ABBVIE INC. | $2.33 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078830 | CMS |
| ABBVIE INC. | $11.67 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078832 | CMS |
| ABBVIE INC. | $27.14 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078834 | CMS |
| ABBVIE INC. | $20.04 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078836 | CMS |
| ABBVIE INC. | $2.40 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078838 | CMS |
| ABBVIE INC. | $7.14 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078840 | CMS |
| ABBVIE INC. | $19.24 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078842 | CMS |
| ABBVIE INC. | $20.86 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078844 | CMS |
| Ferring Pharmaceuticals Inc. | $92.24 | 05/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137487463 | CMS |
| Intercept Pharmaceuticals, Inc. | $19.17 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113644439 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.84 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113644441 | CMS |
| Janssen Biotech, Inc. | $15.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078331597 | CMS |
| Janssen Biotech, Inc. | $23.06 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078331140 | CMS |
| Medtronic, Inc. | $14.76 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119315790 | CMS |
| PENTAX of America, Inc. | $35.11 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119259722 | CMS |
| PENTAX of America, Inc. | $28.94 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119259724 | CMS |
| PENTAX of America, Inc. | $28.94 | 02/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119259726 | CMS |
| PFIZER INC. | $17.94 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131220249 | CMS |
| PFIZER INC. | $14.75 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441185 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.60 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137603045 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.